Robert Denton

Rob Denton is the guiding force behind the operations of Corporate Capital Direct (CCD) and Rx Fund Assist. As a financial and loan industry veteran for over 25 years, he brings a diverse background and deep knowledge of credit and collection policies.

In 2003, after spending many years on one side of the credit marketplace, Rob decided to devote his knowledge and expertise to helping small businesses and individuals to deal head on with credit and collection problems. With the advent of tightening credit markets resulting in cash flow and payable problems, Rob envisioned the development of a different kind of funding source for these day-to-day business challenges.

Rob graduated with a B.A. in Government and Politics from the University of Maryland.

Debra Denton

Nothing goes through CCD without Debra's stamp of approval.

After a top position with a multi-million dollar health insurance company where she was responsible for their internet marketing campaign, managing a budget of more than $100,000 monthly Debra remained in the commercial debt and corporate restructuring space for many years. Developing long term relationships and attention to detail are Debra's trademarks.

With two daughters in medical school and a 10 year old, Debra juggles her corporate responsibilities as well as being the CEO of the household.

Debra graduated with a B.A. in Marketing from the University of Maryland in 1985.

Bud Clarke, ESQ

As a strategic partner, Bud administers key programs and corporate solutions nationally through our NY office. He brings a distinct perspective to our forward thinking business solutions model by leveraging his unique combination of legal training, corporate finance, investment banking and entrepreneurship backgrounds.

Before partnering with CCD Bud spent over a decade building Broadstone Agency Inc., a boutique group benefits and financial services agency located in NY where he is the CEO. Prior to that, Bud was the CEO of Global Capital Securities (NASDAQ GCAP) a national securities firm / investment bank, managing over 1,200 brokers and financial advisers throughout 18 states. While there, GCAP serviced domestic banking clients, including Frontier Airlines and Bud was the investment banker to several international deals typically in the $10MM-$20MM range.

Bud graduated with a B.A. in Political Science from the State University of New York at Fredonia in 1984 and a Juris Doctor degree from California Western School of Law in 1987, admitted to the CA Bar in 1987.

Jonathan Mordis, PHarmD, CPh

Dr. Jonathan Mordis provides consulting services to pharmacies and business operating in the medical and pharmaceutical space with over 20 years experience. Past pharmacy experience ranges from traditional retail pharmacy, compounding pharmacy, pharmacy compliance and pharmacy operations. Jonathan has been part of multiple startups in the healthcare industry which have gone on to be acquired by larger organizations. His offerings for consulting services range from capital funding options with a strong emphasis on vendor pay solutions, business development, and retail sales growth strategies. With a strong understanding of the reimbursement obstacles and market compression forces pharmacy operators face today as well as the constraints these obstacles have in complicating business owners vendor pay situations, Jonathan provides solutions and strategies allowing business owners to focus on day to day operations and less on the challenging and convoluted macro environment.

Jason Melachrino, PharmD, MBA, CPh

Dr. Melachrino has specialized in Geriatrics but has worked through and has intimate knowledge of a variety of settings in Pharmacy (consulting, compounding, retail, institutional, administrative, PBM management and directing inside and outside sales) in the past 18 years. Jason has experience owning, consulting for, building and running compounding and specialty pharmacy operations by generating aggressive sales and growth in those entities through product development, ancillary product sales, services and new verticals. He was an integral part of a partnership which built a compounding company from infancy to an exit through acquisition by an international publicly traded company.($120M+) Dr. Melachrino has joined our team and brings with him his acquired breadth of knowledge in Pharmacy and the medical world by providing sound advise and business direction for our clients.

Jason graduated with a BA in Chemistry from the University of South Florida in 2000, and a PharmD and MBA from Nova Southeastern University in 2004 and 2005 respectively.